Antibody Repertoire Analysis of Hepatitis C Virus Infections Identifies Immune Signatures Associated With Spontaneous

Sivan Eliyahu1, Oz Sharabi2, Shiri Elmedvi1

  • 1Molecular Virology Lab, The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

Frontiers in Immunology
|January 10, 2019
PubMed

Insights

Hepatitis C virus (HCV) infection outcomes can be predicted by analyzing adaptive immune receptor repertoires. Distinct antibody clusters in spontaneous clearers (SC) were identified, aiding in the development of neutralizing antibodies for potential immunotherapies and vaccines.

Area of Science:

  • Immunology
  • Virology
  • Computational Biology

Background:

  • Hepatitis C virus (HCV) infects over 70 million globally, risking severe liver disease.
  • No vaccine exists, and immune responses to HCV, particularly spontaneous clearance (SC) versus chronic infection (CI), are poorly understood.
  • Understanding immune differences between SC and CI individuals can reveal mechanisms of viral control.

Purpose of the Study:

  • To analyze adaptive immune receptor repertoires in individuals with current or past HCV infection.
  • To compare immune responses between spontaneous clearers (SC) and chronically infected (CI) individuals.
  • To identify mechanisms governing viral infection outcomes and develop novel immunotherapies.

Main Methods:

  • In-depth analysis of adaptive immune receptor repertoires.
  • Machine learning framework utilizing antibody characteristics to predict infection outcome.
  • Combinatorial antibody phage display library technology to identify HCV-specific antibody sequences.

Main Results:

  • SC individuals exhibit distinct antibody clusters compared to CI patients.
  • Antibody characteristics accurately predicted HCV infection outcomes using a machine learning model.
  • Two novel antibodies with high neutralization breadth, associated with viral clearance, were constructed.

Conclusions:

  • Distinct adaptive immune responses, particularly antibody profiles, differentiate spontaneous HCV clearance from chronic infection.
  • Machine learning and antibody engineering approaches can predict infection outcomes and generate effective neutralizing antibodies.
  • Findings offer insights into effective immune responses against HCV, potentially guiding prognosis, immunotherapy, and vaccine design.

Related Concept Videos

Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance01:09

Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance

Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
513
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
309
Hepatic Drug Clearance: Effect of Protein Binding01:09

Hepatic Drug Clearance: Effect of Protein Binding

Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
548
Spontaneity02:21

Spontaneity

A spontaneous process is one that occurs naturally under certain conditions. A nonspontaneous process, on the other hand, will not take place unless it is “driven” by the continual input of energy from an external source. Processes have a natural tendency to occur in one direction under a given set of conditions. Water will naturally flow downhill (spontaneous process), but uphill flow (nonspontaneous process) requires outside intervention such as the use of a pump. Iron exposed to...
29.8K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
296
What is the Immune System?01:38

What is the Immune System?

Overview
127.8K